Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania
- 7 February 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 79 (3) , 281-286
- https://doi.org/10.1016/j.lfs.2006.01.002
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Lithium and valproate attenuate dextroamphetamine-induced changes in brain activationHuman Psychopharmacology: Clinical and Experimental, 2005
- Bipolar DisorderNew England Journal of Medicine, 2004
- Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascadeProceedings of the National Academy of Sciences, 2004
- Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imagingBiological Psychiatry, 2003
- Finding the Intracellular Signaling Pathways Affected by Mood Disorder TreatmentsNeuron, 2003
- Neuroprotective effects of lithium in cultured cells and animal models of diseasesBipolar Disorders, 2002
- The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene ExpressionThe Canadian Journal of Psychiatry, 2002
- Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder PatientsAmerican Journal of Psychiatry, 2000
- A Preliminary Investigation of a Protein Kinase C Inhibitor in the Treatment of Acute ManiaArchives of General Psychiatry, 2000
- Hyperactivity induced by dexamphetamine/chlordiazepoxide mixtures in rats and its attenuation by lithium pretreatment: a role for dopamine?Psychopharmacology, 1987